Wang RF - Search Results

1

Identification of MHC class II-restricted tumor antigens recognized by CD4+ T cells.

Wang RF. Wang RF. Methods. 2003 Mar;29(3):227-35. doi: 10.1016/s1046-2023(02)00345-6. Methods. 2003. PMID: 12725788 Review.

2

The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity.

Wang RF. Wang RF. Trends Immunol. 2001 May;22(5):269-76. doi: 10.1016/s1471-4906(01)01896-8. Trends Immunol. 2001. PMID: 11323286 Review.

3

Identification of a mutated fibronectin as a tumor antigen recognized by CD4+ T cells: its role in extracellular matrix formation and tumor metastasis.

Wang HY, Zhou J, Zhu K, Riker AI, Marincola FM, Wang RF. Wang HY, et al. Among authors: wang rf. J Exp Med. 2002 Jun 3;195(11):1397-406. doi: 10.1084/jem.20020141. J Exp Med. 2002. PMID: 12045238 Free PMC article.

4

Induction of CD4(+) T cell-dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells.

Wang HY, Fu T, Wang G, Zeng G, Perry-Lalley DM, Yang JC, Restifo NP, Hwu P, Wang RF. Wang HY, et al. Among authors: wang g, wang rf. J Clin Invest. 2002 Jun;109(11):1463-70. doi: 10.1172/JCI15399. J Clin Invest. 2002. PMID: 12045260 Free PMC article.

5

T cell-mediated immune responses in melanoma: implications for immunotherapy.

Wang RF, Zeng G, Johnston SF, Voo K, Ying H. Wang RF, et al. Crit Rev Oncol Hematol. 2002 Jul;43(1):1-11. doi: 10.1016/s1040-8428(01)00186-x. Crit Rev Oncol Hematol. 2002. PMID: 12098604 Review.

6

Enhancing antitumor immune responses: intracellular peptide delivery and identification of MHC class II-restricted tumor antigens.

Wang RF. Wang RF. Immunol Rev. 2002 Oct;188:65-80. doi: 10.1034/j.1600-065x.2002.18807.x. Immunol Rev. 2002. PMID: 12445282 Review.

7

Identification of HLA-DP3-restricted peptides from EBNA1 recognized by CD4(+) T cells.

Voo KS, Fu T, Heslop HE, Brenner MK, Rooney CM, Wang RF. Voo KS, et al. Among authors: wang rf. Cancer Res. 2002 Dec 15;62(24):7195-9. Cancer Res. 2002. PMID: 12499257

8

Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy.

Wang HY, Lee DA, Peng G, Guo Z, Li Y, Kiniwa Y, Shevach EM, Wang RF. Wang HY, et al. Among authors: wang rf. Immunity. 2004 Jan;20(1):107-18. doi: 10.1016/s1074-7613(03)00359-5. Immunity. 2004. PMID: 14738769 Free article.

9

Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes.

Voo KS, Fu T, Wang HY, Tellam J, Heslop HE, Brenner MK, Rooney CM, Wang RF. Voo KS, et al. Among authors: wang hy, wang rf. J Exp Med. 2004 Feb 16;199(4):459-70. doi: 10.1084/jem.20031219. Epub 2004 Feb 9. J Exp Med. 2004. PMID: 14769850 Free PMC article.

10

Critical role of EBNA1-specific CD4+ T cells in the control of mouse Burkitt lymphoma in vivo.

Fu T, Voo KS, Wang RF. Fu T, et al. Among authors: wang rf. J Clin Invest. 2004 Aug;114(4):542-50. doi: 10.1172/JCI22053. J Clin Invest. 2004. PMID: 15314691 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

601 results

Search Page

Filters